TICE® BCG - BCG LIVE (for Intravesical Use)

Understanding Your Therapy for Bladder Cancer

Welcome to TICEBCG.com, a website where patients like you can find information about therapy for papillary tumors (Ta or T1) and carcinoma in situ (CIS).

This site will help you understand your condition, its treatment with TICE® BCG, and the importance of following your doctor’s instructions to make your treatment as effective as possible.

If you would like to print the information on this website, please click here.

WARNING

TICE® BCG contains live, attenuated mycobacteria. Because of the potential risk for transmission, it should be prepared, handled, and disposed of as a biohazard material (see PRECAUTIONS and DOSAGE AND ADMINISTRATION).

BCG infections have been reported in health care workers, primarily from exposures resulting from accidental needle sticks or skin lacerations during the preparation of BCG for administration. Nosocomial infections have been reported in patients receiving parenteral drugs that were prepared in areas in which BCG was reconstituted. BCG is capable of dissemination when administered by the intravesical route, and serious infections, including fatal infections, have been reported in patients receiving intravesical BCG (see WARNINGS, PRECAUTIONS and ADVERSE REACTIONS).

	Home \| Contact Us \| Privacy \| Terms of Use \| Prescribing Info \| Site Map
	©2008 Organon USA Inc. All Rights Reserved